Trulieve Cannabis is trading 4.42% up at $11.82, but no clear company-specific catalyst dated August 26, 2026 has been identified.
- Latest notable disclosures were second-quarter results on August 7 and completion of the Delaware redomicile on August 11; both are too dated to establish direct causation.
- An August 18 NYSE closing-bell event also predates the move.
- The broader market is mixed, while the supplied consumer-staples context is negative and does not explain the gain. Recheck later for delayed news.